.RESEARCH STUDY HIGHLIGHT.06 August 2024.
A huge randomized regulated trial along with cisgender girls highlights the obstacles of faithfulness to a day-to-day oral preexposure prophylaxis program as well as shows that twice-yearly shot of lenacapavir can easily maintain efficient HIV deterrence amounts over 6 months.